Inventor

NIELSEN ELSEBET OESTERGAARD

DK65 patents

⚠️ This page may combine multiple inventors who share the name “NIELSEN ELSEBET OESTERGAARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NIELSEN ELSEBET OESTERGAARD

NEUROSEARCH AS

Diazabicyclic aryl derivatives and their medical use

1,4-diazabicycloalkane derivatives, their preparation and use

Compounds and their use as positive AMPA receptor modulators

Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Dimeric azacyclic compounds and their use

Azabicyclic aryl derivatives and their medical use

8,10-diaza-bicyclo[4.3.1]decane derivatives and their medical use

Diazabicyclic aryl derivatives as cholinergic receptor modulators

Azabicyclic aryl derivatives

Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance

1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use

Quinuclidine derivatives and their pharmaceutical use

3-heteroaryl-3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonists

Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Diazabicyclic biaryl derivatives

Benzimidazole derivatives and their use for modulating the GABAA receptor complex

Benzimidazole derivatives and their use for modulating the GABAAreceptor complex

Aryl ureido benzoic acid derivatives and their use

Pyridylether derivatives, their preparation and use

8-azabicyclo[3.2.1.]oct-2-ene derivatives, their preparation and use

Enantiomers of 3-heteroaryl-8H-8-azabicyclo(3.2.1)oct-2-ene and their use as monoamine neurotransmitter re-uptake inhibitors

Substituted aryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors

Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Diazabicyclic aryl derivatives

Diazabicyclic aryl derivatives as cholinergy ligands

Certain 9-aza-bicyclo[3.3.1] nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Use of non-competitive and selective GluR5 antagonists as glutamate receptor modulating compounds

Azacyclic ethynyl derivatives

3-substituted quinuclidines and their use

8-aza-bicyclo (3.2.1) octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Aryl and heteroaryl diazabicycloalkanes, their preparation and use

3-substituted quinuclidines and their use as nicotinic agonists

Benzimidazole derivatives and their use for modulating the GABAA receptor complex

1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use

3,8-substituted 8-AZA-bicyclo[3.2.1]octane derivatives and their use as monomine neurotransmitter re-uptake inhibitors

3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

3,9-Diazabicyclo [3.3.1] nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Azaring-ether derivatives and their use as nicotinic ACh receptor modulators

1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use

Azacyclic ethynyl derivatives

PETERS DAN

Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use

Diazabicyclic aryl derivatives as cholinergic receptor modulators

Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use

3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

8-azabicyclo[3.2.1]oct-2-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors